Author: Lily Lieberman
Moving a new drug from lab to market is difficult, time-consuming and expensive for any size pharmaceutical or biotechnology company....
Improve the Value of Your Molecule's Testing with Expert Insight
Our expert team of DDI and drug metabolism consultants can help you piece together the data for a successful data package that meets regulatory expectations for thorough risk assessment of a new or repurposed compound
Read our Follow-Up Interview in Outsourcing Pharma
Find the Q&A between Director of Scientific Consulting, Dr. Maciej Czerwinski, and the editorial team at Outsourcing Pharma for more answers about how DDI testing and data interpretation adds value to the drug repurposing process